|
| |
Histalim, developing personalized medicine
|
|
Histalim develops biomarkers that show a tumor’s immune profile, providing a diagnostic tool that is unique in Europe. The Montpellier company, which joined the Cerba Healthcare group in 2018, is focusing on international development.
|
|
|
|
|
|